Page last updated: 2024-10-22

ambroxol and Liver Dysfunction

ambroxol has been researched along with Liver Dysfunction in 1 studies

Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

Research Excerpts

ExcerptRelevanceReference
"The aim of the study is to examine the effect of Ambroxol on TNF-α and IL-1β released after liver ischemia-reperfusion injury."8.12Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats? ( Cetinel, S; Gultekin, C; Sayiner, S; Sehirli, AO, 2022)
"The aim of the study is to examine the effect of Ambroxol on TNF-α and IL-1β released after liver ischemia-reperfusion injury."4.12Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats? ( Cetinel, S; Gultekin, C; Sayiner, S; Sehirli, AO, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gultekin, C1
Sehirli, AO1
Cetinel, S1
Sayiner, S1

Other Studies

1 other study available for ambroxol and Liver Dysfunction

ArticleYear
Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats?
    Bratislavske lekarske listy, 2022, Volume: 123, Issue:5

    Topics: Ambroxol; Animals; Cytokines; Ischemia; Liver; Liver Diseases; Rats; Rats, Wistar; Reperfusion Injur

2022